258 related articles for article (PubMed ID: 26080303)
1. Risk Factors, Diagnosis, Management, and Outcome of Splanchnic Vein Thrombosis: A Retrospective Analysis.
Derman BA; Kwaan HC
Semin Thromb Hemost; 2015 Jul; 41(5):503-13. PubMed ID: 26080303
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.
Karaköse S; Oruç N; Zengin M; Akarca US; Ersöz G
Turk J Gastroenterol; 2015 Jan; 26(1):42-8. PubMed ID: 25698270
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis.
Darwish Murad S; Valla DC; de Groen PC; Zeitoun G; Haagsma EB; Kuipers EJ; Janssen HL
Am J Gastroenterol; 2006 Jan; 101(1):83-90. PubMed ID: 16405538
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of prothrombotic factors in patients with Budd-Chiari syndrome or non-cirrhotic nonmalignant portal vein thrombosis: A hospital-based observational study.
Fan J; Wang Q; Luo B; Chen H; Wang Z; Niu J; Yuan J; Yuan X; Bai W; He C; Guo W; Li K; Yin Z; Fan D; Han G
J Gastroenterol Hepatol; 2020 Jul; 35(7):1215-1222. PubMed ID: 31711259
[TBL] [Abstract][Full Text] [Related]
5. PAI-1 4G-4G, MTHFR 677TT, V Leiden 506Q, and Prothrombin 20210A in Splanchnic Vein Thrombosis: Analysis of Individual Patient Data From Three Prospective Studies.
Pasta L; Pasta F; D'Amico M
J Clin Exp Hepatol; 2016 Mar; 6(1):10-4. PubMed ID: 27194890
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of thrombosis in abdominal veins.
Dutta AK; Chacko A; George B; Joseph JA; Nair SC; Mathews V
World J Gastroenterol; 2008 Jul; 14(28):4518-22. PubMed ID: 18680232
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of JAK29V617F) mutation in intra-abdominal venous thrombosis.
Deepak A; Punamiya S; Patel N; Parekh S; Mehta S; Shah N
Trop Gastroenterol; 2011; 32(4):279-84. PubMed ID: 22696908
[TBL] [Abstract][Full Text] [Related]
8. Thrombophilia Profile in Budd-Chiari Syndrome and Splanchnic Vein Thrombosis: A Study from Western India.
Sawant P; Vashishtha C; Nasa M; Parikh P; Patel J; Agasti A
J Assoc Physicians India; 2015 Sep; 63(9):32-5. PubMed ID: 27608864
[TBL] [Abstract][Full Text] [Related]
9. Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome.
Ageno W; Dentali F; Pomero F; Fenoglio L; Squizzato A; Pagani G; Re R; Bonzini M
Thromb Haemost; 2017 Apr; 117(4):794-800. PubMed ID: 28180235
[TBL] [Abstract][Full Text] [Related]
10. JAK2 mutations across a spectrum of venous thrombosis cases.
Shetty S; Kulkarni B; Pai N; Mukundan P; Kasatkar P; Ghosh K
Am J Clin Pathol; 2010 Jul; 134(1):82-5. PubMed ID: 20551270
[TBL] [Abstract][Full Text] [Related]
11. Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation.
Colaizzo D; Amitrano L; Guardascione MA; Tiscia GL; D'Andrea G; Longo VA; Grandone E; Margaglione M
Thromb Res; 2013 Aug; 132(2):e99-e104. PubMed ID: 23916380
[TBL] [Abstract][Full Text] [Related]
12. Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.
De Stefano V; Qi X; Betti S; Rossi E
Thromb Haemost; 2016 Jan; 115(2):240-9. PubMed ID: 26333846
[TBL] [Abstract][Full Text] [Related]
13. JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease.
Allegra A; Alonci A; Penna G; D'Angelo A; Rizzotti P; Granata A; Musolino C
Acta Haematol; 2009; 121(4):218-20. PubMed ID: 19478480
[TBL] [Abstract][Full Text] [Related]
14. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby IL; Kapraali M; Kechagias S; Lindahl TL; Almer S
Thromb Res; 2014 Aug; 134(2):455-61. PubMed ID: 24913997
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Janus Kinase 2 mutations in patients with unusual site venous thrombosis.
Basquiera AL; Tabares AH; Soria N; Salguero M; Ryser R; García JJ
Medicina (B Aires); 2011; 71(4):313-6. PubMed ID: 21893442
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis.
Yonal I; Pinarbası B; Hindilerden F; Hancer VS; Nalcaci M; Kaymakoglu S; Diz-Kucukkaya R
J Thromb Thrombolysis; 2012 Oct; 34(3):388-96. PubMed ID: 22569900
[TBL] [Abstract][Full Text] [Related]
17. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis.
Primignani M; Barosi G; Bergamaschi G; Gianelli U; Fabris F; Reati R; Dell'Era A; Bucciarelli P; Mannucci PM
Hepatology; 2006 Dec; 44(6):1528-34. PubMed ID: 17133457
[TBL] [Abstract][Full Text] [Related]
18. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India.
Mohanty D; Shetty S; Ghosh K; Pawar A; Abraham P
Hepatology; 2001 Oct; 34(4 Pt 1):666-70. PubMed ID: 11584361
[TBL] [Abstract][Full Text] [Related]
19. Survival after splanchnic vein thrombosis: A 20-year nationwide cohort study.
Søgaard KK; Darvalics B; Horváth-Puhó E; Sørensen HT
Thromb Res; 2016 May; 141():1-7. PubMed ID: 26945454
[TBL] [Abstract][Full Text] [Related]
20. Prothrombotic states in portal vein thrombosis and Budd-Chiari syndrome in India: A systematic review and meta-analysis.
Giri S; Angadi S; Varghese J; Sundaram S; Bhrugumalla S
Indian J Gastroenterol; 2023 Oct; 42(5):629-641. PubMed ID: 37610562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
